Savvy Updates, 2/3/25: Ozempic OK’ed for Kidney Health, PREPARENESS & Go Bags, Anti-Aging Drugs, Sparkling Water & Weight Loss
FDA clears use of Ozempic to protect kidney health by Kristin Jensen for BioPharmaDive.com, 29 January 2025. Novo Nordisk won an expanded approval for Ozempic, allowing the company to market its top-selling medicine to reduce the risk of kidney complications in adults...
Savvy Updates, 1/27/25: Insulin Costs Drop, Omnipod Dash Travel Alert, FDA At-a-Glance Nutrition Info, Modulim & Amputation Research, FTC’s Ultimatum to CVS Health, ADA & Xeris on Hypoglycemia Education, Turmeric & Diabetes, Why US Healthcare is Broken
In this week’s issue of The Savvy Diabetic: Insulin Costs Drop Omnipod Dash Travel Alert FDA At-a-Glance Nutrition Info Modulim & Amputation Research FTC’s Ultimatum to CVS Health ADA & Xeris on Hypoglycemia Education Turmeric & Diabetes...
Savvy Update, 1/20/25: Glucagon RXs UP … BUT, Gut Bacterium Helps Cut Sugar Cravings, FDA Bans Red Dye, Red Meat Increases Dementia Risk, Empathy-Focused Calls Boost Self-Care, FTC 2nd Report Slams PMBs, BG Levels Pasta/Pizza Spike More in America, California Insulin Delayed, Ozempic Picked for Medicare Price Reduction, Adam Brown on Self-Talk & Juggling, Clinical Trial T1D & CKD, Omnipod Next-Gen?
LOTS to READ in this week’s issue of The Savvy Diabetic: Glucagon Prescriptions are UP … BUT Fall Short of Meeting Demand Special Gut Bacterium Could Help Cut Sugar Cravings FDA bans controversial red dye Processed Red Meat Increases Dementia Risk...
Savvy Updates, 1/13/25: Sana Islet Cell Transplants w/out Immunosuppression, Beta Bionics Files IPO, Glooko/Hedia Launches D Management Tech, CeQur $$ for Simplicity Patch Pump, Glucose Monitoring with Sweat, Medical Debt Removed from Credit, Coffee Best in AM
Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression released by Sana.com, 7 January 2025. Sana Biotechnology, Inc., a company focused on changing the possible for patients through...
Savvy Updates, 9/16/24: Abbott Libre 3 Recall, FDA Clears Modular Medical PODD1 Pump, Air Flight Can Disrupt Pump Insulin Delivery, Roche to Launch Accu-Chek Smartguide CGM, Ozempic/Mounjaro & Metformin, Abvance Therapeutics Gets $3.9M for Novel Insulin & Glucagon Formulation, Dexcom CGM Worn in Space for 1st Time, Drug Interactions with GLP-1 Agonists & SGLT-2 Inhibitors, Semaglutide Impact on Body Composition, 4 largest PBMs Control 70% of Prescription Drug Market, Banana Leaves as New Source of Protein Powder
Continuous Glucose Monitoring (CGM) Sensor Recall: Abbott Diabetes Care Inc Issues Recall for Certain FreeStyle Libre 3 Sensors due to Risk for Inaccurate High Glucose Readings posted by FDA.gov/medical-devices, 5 September 2024. This recall involves removing...
More Diabetes Blogs